Patent issuance expands United States patent coverage for AVERSA transdermal abuse deterrent technology AVERSA transdermal abuse deterrent technology is protected by a broad international intellectual ...

Nutriband's lead product under development is Aversa™ Fentanyl, an abuse deterrent fentanyl transdermal system, with the potential to become the first abuse deterrent pain patch on the market with ...

Some are concerned the heightened focus on violent crime and immigration risks diverting attention from complicated criminal and national security threats.